| Title: |
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial |
| Authors: |
Burrell, Rebecca A.Aff1; Kumar, SanjeevAff1, Aff15; Provenzano, ElenaAff2; Pike, CleopatraAff3; Dayimu, AlimuAff4; McIntosh, Stuart A.Aff5; Pitsinis, VassilisAff6; King, PollyAff7; Elsberger, BeatrixAff8; Govindarajulu, SasiAff9; Satherley, LucyAff10; Hadad, SirwanAff11; Schmid, PeterAff12; Agrawal, AmitAff13; Akpuluma, BodiereAff1; Bell, StevenAff1; Benson, John R.Aff13; Caldas, CarlosAff1; Cheeseman, DanyaAff14; Chernukhin, IgorAff14; Forouhi, PartoAff13; Gulsen, TulayAff4; Kleidi, EleftheriaAff13; Pinilla, KarenAff1; Qian, WendiAff4; Abraham, Jean E.Aff1; Carroll, Jason S.Aff14; Baird, Richard D.Aff1, IDs4301802501087x_cor1 |
| Source: |
Nature Cancer. 7(1):194-206 |
| Database: |
Springer Nature Journals |